1114. Comparative analysis between Polymerized Type I Collagen and Baricitinib as potential treatment for COVID-19

BACKGROUND: Baricitinib is a treatment authorized by the FDA for the treatment of moderate to severe COVID-19, despite this there are few approved drugs; polymerized type I collagen (PTIC) is a drug that has been used in Mexico with great potential for treating moderate to severe cases of COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Carpio-Orantes, Luis Del, García-Mendez, Sergio, Sánchez-Díaz, Jesús Salvador, Aguilar-Silva, Andrés, García-Hernández, Omar, Salazar-Lizárraga, Raúl Enrique, González-Arce, América Alejandrina, Martínez-Rojas, Manuel, Jiménez-Flores, Oscar Rodrigo, Villalobos-López, Luis Roberto, Hernández-Gómez, Héctor Nahín, Domínguez-Cámara, Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752297/
http://dx.doi.org/10.1093/ofid/ofac492.953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752297/
http://dx.doi.org/10.1093/ofid/ofac492.953

Ejemplares similares